Improved Serum Alpha-Fetoprotein Levels after Iron Reduction Therapy in HCV Patients
ISRN Hepatology · 2014
DOI: 10.1155/2014/875140 ↗Abstract
Background and Aims . To examine the changes in serum alpha-fetoprotein (AFP) levels after iron reduction by therapeutic phlebotomy in chronic hepatitis C patients. Methods . This retrospective study included 26 chronic hepatitis C patients. The patients were developed iron depletion by repeated therapeutic phlebotomies. Results . Iron reduction therapy significantly reduced the median level of serum AFP from 13 to 7 ng/mL, ALT from 96 to 50 IU/L, gamma-glutamyl transpeptidase (GGT) from 55 to 28 IU/L, and ferritin from 191 to 10 ng/mL ( P < 0.001 for each). The rate of decline in the AFP level correlated positively only with that in GGT ( r = 0.695 , P = 0.001 ) , although a spurious correlation was observed between the rates of decline for AFP and ALT. The AFP level normalized (
EUVIMED